Clin Med Flashcards
Overweight
BMI 25-29.9
Obese
BMI 30+
BMI
weight (kg) / height (m^2)
When to measure waist circumference?
If BMI b/w 25-35
Increased cardiometabolic risk based on Weight circumference
M: 40+ inches
F: 35+ inches
Increased cardiometabolic risk based on Weight circumference (Asian)
M: 35.4+ inches
F: 31.5+ inches
As people lose weight
metabolism tends to slow down, making it harder to continue losing weight
How to lose weight by creating negative energy balance
Crease 500-1000 calorie per day deficit= 1-2 lbs of weight loss per week
Goals of weight loss
Initial goal:
5-7% of body weight
loss of >5% reduces risk factors for CVD
Commonly rec diets for weight loss and protection against DM and CAD
Mediterannean: low meat, fat is from olive oil, plant based
DASH (to stop HTN): veggies, fruit, low fat dairy, whole grains, fish, poultry, buts
Recommended for all of the following: Type 2 DM, CVD, Kidney dz
DASH
Intermittent fasting
Promote weight loss
Improves lipids
Reduces BP, fasting BS, and A1C
Obesity screening
Screen ALL Adults
if BMI 30+: refer for intensive, multicomponent behavioral intervention
If diagnosed obese, what is considered comprehensive and high intensity intervention?
2x/month for at least 3 months
12-26 sessions/year
The most important factor in a lifestyle change plan
Readiness to change
Low risk
BMI 25-29.9 with NO CVD, Risk factors, or other comorbidities
Tx: diet/exercise counseling
Moderate risk
BMI 25-29.9 AND 1 or more Risk factor
OR
BMI 30-34.9
Tx: intensive, multicomponent behavior modification + drug therapy for SOME
High risk
BMI 35-40
Intensive, multicomponent behavior modification + consider drug therapy or Surgery
Very high risk
BMI >40
Intensive, multicomponent behavior therapy + consider drug therapy or Surgery
When to consider meds for Obesity
BMI 30+ or >27 with comorbidity
When to consider meds for Obesity
AFTER 3-6 months, if <5% weight loss has been achieved
Goals of drug therapy
reduce weight by 4-8% within 6-12 months
Orlistat (Alli/Xenical)
Inhibit pancreatic lipase, altering fat digestion
Fatty stools, Unpleasant GI SE
Take Vitamin!! (may decrease absorption of fat soluble vitamins, ADEK)
Liraglutide (Victoza)
GLP-1 RA
(also a DM drug, Type 2)
Daily SQ injection
Phentermine/ Topiramate
DO NOT USE in pts with HTN, CAD, or Hyperthyroid
Phentermine
Symp-mimetic
DO NOT USE in pts with HTN, CAD, or Hyperthyroid
only FDA app for short term- 12 wks
The most widely prescribed wt loss drug
More SE- careful with addictive personalites
Bariatric surgery
Efficient, improve DM and HTN, lower long term mortality rates
Consider bariatric surgery with
BMI 40+
BMI 35-40 AND 1 or more other serious comorbidity
BMI 30-35 AND uncontrollable DM2 or Metabolic syndrome
Why is it important to lose weight before bariatric surgery?
Loss of 8% excess body weight prior to surgery leads to greater weight loss post op
CONTRA-indications to bariatric surgery
Eating disorder Untreated mental illness Drug/Alc abuse Coagulopathy Severe cardiac dz Cannot comply w new diet
Bariatric surgery can cause wt loss in many ways:
Restriction (make stomach smaller)
Malabsorption (make small bowel shorter)
Decrease appetite/ improve metabolsim (change release of hormones)
Exercise recommendation
aerobic
150-300 min of MODERATE
OR
75-150 min of VIGOROUS
Exercise recommendation
muscle strengthening
2 or more days/week
Hormones released from Ant Pit (6)
ACTH TSH LH FSH GH Prolactin
Ant Pit
Makes AND Secretes hormones in response to negative fdback from Adrenal, Thyroid, and Gonads
ACTH
stimulates production and release of Cortisol
LH in females
Triggers ovulation (LH Surge) and development of Corpus Luteum
LH in males
Tells Leydig cells to produce Testosterone
FSH in females
Growth of ovarian follicles
FSH in males
formation of Secondary spermatocytes
Prolactin in males
Work with LH and Testosterone to increase reproductive function
Posterior pit
ONLY RELEASES hormones that are made in hypothalamus
Intermediate pituitary
AKA
“Pars Intermedia”
MAKES and SECRETES Melanocyte stimulating hormone- skin pigmentation
ACTH made by
Corticotrophs
TSH made by
Thyrotrophs
LH and FSH made by
Gonadotrophs
GH made by
Somatotrophs
Prolactin made by
Lactotrophs
Sellar Mass clinical sx
Visual, diplopia, HA
Incidental finding on MRI
Why does visual change occur w Sellar mass?
Suprasellar extension of adenoma compressing the Optic Chaism
“Bitemporal hemianopsia”
AKA tunnel vision
Type of Sellar mass: Benign Tumor
Pituitary adenoma is a type of BENIGN
Most common Pituitary adenoma (a benign Sellar mass)
Prolactinoma
Clinical sx of Prolactinoma in pre-menopausal women
No period
Infertile
Galactorrhea
Serum prolactin level: >30
Clinical sx of Prolactinoma in post-menopausal women
HA
Impaired vision
Galactorrhea
Serum prolactin level >20
Clinical sx of Prolactinoma in Men
Decreased libido
ED, infertile
Gyencomastea
Serum prolactin level >20
Tx of Prolactinoma
Cabergoline (pharm)
OR
Transsphenoidal resection (standard of care)
GH excess most common cause
Benign pituitary macroadenoma (from somatotrophs)
Acromegaly
ADULTS
Increased risk of DM, HTN, and CAD
Growth Hormone Excess Dx
OGTT: >1 after two hours
GOLD STANDARD
Can also do IGF-1 levels, MRI
Tx of GH excess
Transsphenoidal Microsurgery: most successful in pts iwth GH <50 and tumor <2cm
Pharm: Somatostatin analog (Octreotide/lanreotide)
Monitoring of GH excess
IGF-1 levels every 3-6 months
GH deficiency (not enough)
Pit adenoma or after tx of tumor (removed too much)
Rare: Sheehan synd
GH deficiency in adults
Tumors are #1 cause